Skip to main content
. 2021 Jul 21;15:684019. doi: 10.3389/fnbot.2021.684019

Table 3.

Treatment group analysis.

Treatment group analysis CIMT Robotic Therapy p-value
WMFT median time, seconds −24.36 (−133.80−5.08) −11.09 (−27.56−8.87) 0.293
FMA—UL 4.5 (1.5−7) 2.7 (−2−6) 0.187
WMFT (Ability) 0.27 (0.1−0.7) 0.30 (0.27−0.6) 0.769
AMAT (Ability) 0.27 (0.19−0.91) 0.41 (0.17−0.79) 0.988
AMAT (Quality) 0.50 (0.22−0.79) 0.53 (0.17−0.89) 0.792
MAS −0.05 (−0.66−0) 0 (−0.11−0.05) 0.014
FIM 1.5 (0−5.25) 3.0 (2.0−5.75) 0.517
SIS (total score) 6.77 (0−15.20) 7.04 (1.89−11.64) 0.761
    SIS strength 0 (−12.5−18.75) 15.63 (−6.25−25) 0.122
    SIS Activities of Daily Living 10 (0−15) 10.0 (−2.5−17.5) 0.855
    SIS Hand Function 15.0 (5−25) 17.5 (5.0−25) 0.939

CMIT, constraint-induced movement therapy; WMFT, wolf motor function test (mean time in seconds); FMA—UL, upper limb fugl meyer assessment; AMAT, arm motor ability test; MAS, modified ashworth scale; FIM, functional independence measure; SIS, stroke impact scale;

Median change from baseline.